LRF Scientific Advisory Board Members to be Joined by Current and Former Grantees at the 59th ASH Annual Meeting & Exposition
New York, NY (December 7, 2017) –The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive portfolio of education programs, outreach initiatives and patient services – will return to the American Society of Hematology (ASH) Annual Meeting and Exposition, with more than 114 LRF affiliated scientists, including past and present members of LRF’s world-leading Scientific Advisory Board and grantees, presenting their findings at this year’s conference.
Widely regarded as the premier event in malignant and non-malignant hematology, the ASH Annual Meeting, held from December 9-12, 2017 in Atlanta, GA, provides a critical forum for leading
hematologists /oncologists to present their findings to over 20,000 of their peers. Of the 137 grantees funded by the Lymphoma Research Foundation over the past decade, 61 percent will be presenting data at this year’s meeting alone. Among the distinguished scientists invited to present, LRF will see 77 percent of its LRF Scholars — participants in LRF’s Lymphoma Clinical Mentoring Program – present abstracts at the 59th ASH Annual Meeting.
“The fact that we have 93 percent of LRF’s Scientific Advisory Board (SAB) members presenting at this year’s ASH Annual Meeting speaks to the caliber of world-leading scientists we have steering LRF’s research investment and patient education,” said Thomas M. Habermann, MD, Chair of the LRF Scientific Advisory Board. “As Chair of this prestigious board, I am encouraged and proud of the incredible research being presented by the early career scientists we support as well.”
The 2018 ASH Annual Meeting will also feature 16 abstracts and presentations stemming from LRF-funded research.
“We are incredibly proud to work with and support scientists who are making strides in advancing lymphoma research,” said LRF Chief Executive Officer Meghan Gutierrez. “We are grateful to have the expertise of our Scientific Advisory Board to guide our research investment, so that we can continue to make a meaningful impact on the future of lymphoma research, which is evident in the number of young investigators supported by LRF presenting at this year’s ASH.”
Throughout this year’s ASH Annual Meeting, members of the Lymphoma Research Foundation Executive Team will be available for comment on ongoing ASH presentations and findings. For requests for real-time comment, please contact Peggy Ann Torney, Chief Strategy, Communications and Engagement Officer, at firstname.lastname@example.org or (646) 300-5506.
About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded nearly $60 million in lymphoma-specific research.
For additional information on LRF’s research, education and services, visit lymphoma.org.